Morten Brændvang
University of Oslo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Morten Brændvang.
Bioorganic & Medicinal Chemistry | 2009
Morten Brændvang; Vebjørn Bakken; Lise-Lotte Gundersen
6-Benzofuryl-, styryl, benzyl, and furfurylpurines as well as 6-[1(3H)-isobenzofuranylidenemethyl]purines have been synthesized and their activities against Mycobacterium tuberculosis (Mtb) determined. Several compounds displayed profound antimycobacterial activity in combination with low toxicity towards mammalian cells. NMR and X-ray crystallography were employed to determine the detailed structures and the results were supported by quantum chemical calculations.
Bioorganic & Medicinal Chemistry | 2010
Matthew Lovell Read; Morten Brændvang; Pedro O. Miranda; Lise-Lotte Gundersen
Pyrimidine analogs of antimycobacterial 6-aryl-9-benzylpurines have been synthesized and screened for antibacterial activity against Mycobacterium tuberculosis H(37)Rv in vitro. Several active compounds were identified and the best results were observed for 5-formamidopyrimidines. These compounds generally displayed IC(90) values < or =1microg/mL, and they exhibited low toxicity towards mammalian cells. Imidazolylpyrimidines, which may be regarded as fleximer analogs of the parent purines, were also synthesized and one of them was found to be quite a potent inhibitor of M. tuberculosis (IC(90) 14microg/mL).
Bioorganic & Medicinal Chemistry Letters | 2009
Morten Brændvang; Colin Charnock; Lise-Lotte Gundersen
Pyrimidine analogs of antimycobacterial purines have been synthesized and their biological activities evaluated. Several 5-formamidopyrimidines exhibited profound activity against Mycobacterium tuberculosis in vitro (IC(90)< or =1.5 microg/mL), and they were essentially inactive against other bacteria.
Acta Crystallographica Section C-crystal Structure Communications | 2007
Morten Brændvang; Lise-Lotte Gundersen
The title compound, C(17)H(13)ClN(4)O(2), displays profound and selective activity against Mycobacterium tuberculosis. In the crystal structure, there are two independent molecules in the asymmetric unit. Intermolecular hydrogen bonding between a CH group of the purine ring and the O atom of the furan ring, and also pi-pi stacking in another direction, builds the three-dimensional network.
Bioorganic & Medicinal Chemistry | 2005
Morten Brændvang; Lise-Lotte Gundersen
Bioorganic & Medicinal Chemistry | 2007
Morten Brændvang; Lise-Lotte Gundersen
Tetrahedron Letters | 2007
Morten Brændvang; Lise-Lotte Gundersen
Tetrahedron | 2009
Ágnes Proszenyák; Morten Brændvang; Colin Charnock; Lise-Lotte Gundersen
Synthesis | 2006
Morten Brændvang; Lise-Lotte Gundersen
Acta Crystallographica Section E: Crystallographic Communications | 2007
Morten Brændvang; Lise-Lotte Gundersen
Collaboration
Dive into the Morten Brændvang's collaboration.
Oslo and Akershus University College of Applied Sciences
View shared research outputs